We all are extremely conscious towards the health realted concerns, hence it is important to eat balanced and protein-rich diet in our daily routine. Today, soyabean is considered as a healthy source of proteins, vitamins and saturated ...
Tags: Soyabean, Processing Machinery
Gord McNeil, prostate-cancer survivor and the past president of the Toronto Transportation Club (TTC), has officially issued a MOvember challenge to his other truckers in the area. "We need to get the word out to all males over 40 to get ...
Tags: Transportation, bike, Auto Parts
The University of Michigan’s Department of Pathology MLabs has announced the commercial availability of Mi-prostate score (MiPS) test for men, a new urine test that measures minute fragments of RNA in prostate cancer. The test ...
Tags: Prostate Cancer, Medicine
LifeAgain Insurance Solutions, a wholly-owned subsidiary of Cardium Therapeutics, has signed a commercialisation agreement with insurance broker AgencyONE to support the development and marketing of new survivable risk life insurance ...
Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers. The Janssen Research & Development will manage compound ...
Berg has signed a cooperative research and development agreement with the US Department of Defense, to advance prostate cancer research. The Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research ...
Tags: Berg, Prostate Cancer Research
Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
Astellas Pharma has announced the availability of Xtandi (enzalutamide), a new treatment for advanced prostate cancer in patients who have failed on first-line hormonal treatments and docetaxel chemotherapy, in the UK. Administered ...
Tags: Astellas, Cancer Medication
US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...
Tags: Johnson&Johnson, Medicine
The US Patent and Trademark Office (USPTO) has granted a patent to GenSpera for the activation of peptide prodrugs by HK2, which is an enzyme secreted by prostate cancer cells. Composition of a series of prodrugs activated by HK2 enzyme ...
Tags: Peptide Prodrugs, Medicine
Astellas Pharma and Medivation have announced the Health Canada approval of Xtandi (enzalutamide) capsules to treat metastatic castration-resistant prostate cancer. The oral, once-daily androgen receptor inhibitor is indicated for ...
Tags: Astellas Pharma, Medicine
Perhaps prompted by all the ads for drugs such as AndroGel 1.62% and Axiron, many men attribute their lagging libido to reduced testosterone levels. But stress, depression, lack of sleep or exercise, work load, or changed feelings about ...
Tags: Low-T, Health&Medicine
Reusable plastic water bottles may be good for the environment, but a new study shows they might be bad for your health. There's a possibility that the chemical found in plastic water bottles, baby bottles and the lining of many food, ...
Tags: baby bottle, child bottle
Astellas Pharma and Medivation have announced the submission of application for marketing approval of enzalutamide in Japan for the treatment of prostate cancer. The application was filed by Astellas with the Ministry of Health, Labour ...
Tags: Astellas, Marketing Application
The US FDA has approved Algeta's Xofigo (radium-223 dichloride) injection for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. Xofigo is the first ...